Christine Léauté-Labrèze is an expert in Dermatology at Centre Hospitalier Universitaire de Bordeaux (France). As of October 2026, ScienceLeadR ranks Christine Léauté-Labrèze in the top 1% of experts worldwide for Hemangioma. Christine Léauté-Labrèze has authored 293 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 799 (community average: 125). How the SLR is computed.

LeadR Profile

Christine Léauté-Labrèze Centre Hospitalier Universitaire de Bordeaux France
799 ScienceLeadR Reputation 799
Network Map

Dermatology

Subspecialties: Pediatrics - Hematology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

University of Bordeaux

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 293

Citations

Citations: 11 723 1st author: 34 Last author: 62 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Peripheral vasomotor symptoms: Expanding the phenotype of GNA11-related capillary malformations.
PMID 42755085 — sexually transmitted diseases, capillaries, mosaicism, phenotype, skin diseases, signs and symptoms
J Eur Acad Dermatol Venereol20260
Cherry Angiomas in Individuals With Neurofibromatosis Type 1.
PMID 42616496 — cells, neoplasms, skin diseases, odds ratio, prevalence, neurofibromatosis 1, sex, endothelial cells, neurofibromatoses
JAMA Dermatol20260
Germline EZH2 mutation cooperates with somatic KIT D816V to drive early pediatric advanced systemic mastocytosis.
PMID 42610275 — mastocytosis, systemic, mastocytosis, mutation
Haematologica20260
Pediatric Phthiriasis Palpebrarum: A French Multicentric Retrospective Study of 20 Cases.
PMID 42437072 — eyelids, retrospective studies, diagnosis, therapeutics, pediatrics, child abuse, child
J Pediatr Clin Pract20260
Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED ohort).
PMID 42348162 — dermatitis, alopecia areata, pharmaceutical preparations, adrenal cortex hormones, maintenance, therapeutics, methotrexate, child, alopecia, dermatitis, atopic
Paediatr Drugs20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 2 3
Phase 2/Phase 3 1
Phase 3 1

By status:

Completed 5
Recruiting 2
Unknown 1

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 6

Main Topics

LeadR Networks

Main global connection map